US Stock MarketDetailed Quotes

TCRT Alaunos Therapeutics

Watchlist
  • 2.0900
  • -0.2476-10.59%
Close Nov 15 16:00 ET
  • 2.2000
  • +0.1100+5.26%
Post 19:16 ET
3.35MMarket Cap-282P/E (TTM)

Alaunos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
75.99%-1.68M
79.57%-1.92M
-3.11%-30.14M
-3.58%-7.39M
-3.73%-6.37M
14.47%-7M
-20.73%-9.38M
52.44%-29.23M
52.86%-7.13M
35.84%-6.15M
Net income from continuing operations
87.14%-1.13M
83.26%-1.68M
6.86%-35.14M
14.37%-7.84M
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
Operating gains losses
----
----
0.00%7K
---5K
--2K
----
----
--7K
----
----
Depreciation and amortization
-99.86%1K
-99.71%2K
-16.09%2.32M
-65.27%241K
-1.74%679K
2.04%699K
1.02%696K
6.24%2.76M
-1.56%694K
2.67%691K
Other non cash items
----
----
-0.52%1.33M
25.39%-1.1M
13.57%385K
-30.33%1.46M
54.76%585K
4,203.23%1.33M
-457.52%-1.47M
-0.29%339K
Change In working capital
49.85%-656K
73.16%-409K
-818.85%-6.25M
-241.42%-2.72M
-180.76%-701K
35.25%-1.31M
-1,655.10%-1.52M
-72.30%870K
131.51%1.92M
-91.12%868K
-Change in receivables
25.00%-3K
--0
-99.73%3K
-100.03%-1K
100.14%4K
---4K
-99.64%4K
-68.86%1.11M
626.75%2.91M
-147.60%-2.91M
-Change in prepaid assets
-195.81%-320K
526.53%307K
-256.52%-1.36M
-2,646.00%-1.27M
-193.21%-467K
100.00%334K
-67.11%49K
-90.56%867K
-96.76%50K
-72.56%501K
-Change in payables and accrued expense
40.64%-333K
50.42%-716K
-587.16%-4.76M
14.89%-2.41M
-110.14%-345K
-96.84%-561K
-47.80%-1.44M
93.23%-693K
62.57%-2.83M
65.68%3.4M
-Change in other current assets
----
----
281.68%500K
--0
----
----
----
-34.83%131K
--0
--0
-Change in other current liabilities
--0
--0
-17.71%-638K
-46.42%965K
-214.40%-393K
46.89%-1.08M
30.00%-133K
-224.88%-542K
1,159.41%1.8M
47.70%-125K
Cash from discontinued investing activities
Operating cash flow
75.99%-1.68M
79.57%-1.92M
-3.11%-30.14M
-3.58%-7.39M
-3.73%-6.37M
14.47%-7M
-20.73%-9.38M
52.44%-29.23M
52.86%-7.13M
35.84%-6.15M
Investing cash flow
Cash flow from continuing investing activities
0
0
797.41%1.35M
1,716.13%1.5M
107.14%1K
-136.84%-135K
20.69%-23K
94.19%-193K
74.09%-93K
96.22%-14K
Net PPE purchase and sale
--0
--0
797.41%1.35M
1,716.13%1.5M
107.14%1K
-136.84%-135K
20.69%-23K
94.19%-193K
74.09%-93K
96.22%-14K
Cash from discontinued investing activities
Investing cash flow
--0
--0
797.41%1.35M
1,716.13%1.5M
107.14%1K
-136.84%-135K
20.69%-23K
94.19%-193K
74.09%-93K
96.22%-14K
Financing cash flow
Cash flow from continuing financing activities
0
0
-384.88%-18.14M
0
0
-11.98M
-6.16M
-75.30%6.37M
4,655.91%8.47M
-108.45%-2.11M
Net issuance payments of debt
--0
--0
-117.27%-18.11M
--0
--0
---11.86M
---6.25M
-133.33%-8.33M
---6.25M
---2.08M
Net common stock issuance
--0
--0
-99.37%92K
--0
--0
--0
--92K
--14.68M
--14.72M
---45K
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
-97.97%21K
--0
----
Net other financing activities
----
----
---125K
--0
--0
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
-384.88%-18.14M
--0
--0
---11.98M
---6.16M
-75.30%6.37M
4,655.91%8.47M
-108.45%-2.11M
Net cash flow
Beginning cash position
-88.93%4.15M
-88.56%6.06M
-30.32%53M
-76.92%11.94M
-69.48%18.32M
-45.16%37.43M
-30.32%53M
-33.91%76.05M
-43.59%51.75M
-21.81%60.01M
Current changes in cash
91.21%-1.68M
87.68%-1.92M
-103.55%-46.93M
-570.18%-5.88M
22.90%-6.37M
-131.89%-19.12M
-99.54%-15.56M
40.90%-23.06M
107.98%1.25M
-155.18%-8.27M
End cash Position
-86.55%2.46M
-88.93%4.15M
-88.56%6.06M
-88.56%6.06M
-76.92%11.94M
-69.48%18.32M
-45.16%37.43M
-30.32%53M
-30.32%53M
-43.59%51.75M
Free cash flow
76.45%-1.68M
79.70%-1.92M
-3.03%-30.34M
-1.92%-7.39M
-3.51%-6.38M
13.43%-7.14M
-21.07%-9.44M
54.55%-29.45M
53.21%-7.25M
38.08%-6.16M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 75.99%-1.68M79.57%-1.92M-3.11%-30.14M-3.58%-7.39M-3.73%-6.37M14.47%-7M-20.73%-9.38M52.44%-29.23M52.86%-7.13M35.84%-6.15M
Net income from continuing operations 87.14%-1.13M83.26%-1.68M6.86%-35.14M14.37%-7.84M4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M
Operating gains losses --------0.00%7K---5K--2K----------7K--------
Depreciation and amortization -99.86%1K-99.71%2K-16.09%2.32M-65.27%241K-1.74%679K2.04%699K1.02%696K6.24%2.76M-1.56%694K2.67%691K
Other non cash items ---------0.52%1.33M25.39%-1.1M13.57%385K-30.33%1.46M54.76%585K4,203.23%1.33M-457.52%-1.47M-0.29%339K
Change In working capital 49.85%-656K73.16%-409K-818.85%-6.25M-241.42%-2.72M-180.76%-701K35.25%-1.31M-1,655.10%-1.52M-72.30%870K131.51%1.92M-91.12%868K
-Change in receivables 25.00%-3K--0-99.73%3K-100.03%-1K100.14%4K---4K-99.64%4K-68.86%1.11M626.75%2.91M-147.60%-2.91M
-Change in prepaid assets -195.81%-320K526.53%307K-256.52%-1.36M-2,646.00%-1.27M-193.21%-467K100.00%334K-67.11%49K-90.56%867K-96.76%50K-72.56%501K
-Change in payables and accrued expense 40.64%-333K50.42%-716K-587.16%-4.76M14.89%-2.41M-110.14%-345K-96.84%-561K-47.80%-1.44M93.23%-693K62.57%-2.83M65.68%3.4M
-Change in other current assets --------281.68%500K--0-------------34.83%131K--0--0
-Change in other current liabilities --0--0-17.71%-638K-46.42%965K-214.40%-393K46.89%-1.08M30.00%-133K-224.88%-542K1,159.41%1.8M47.70%-125K
Cash from discontinued investing activities
Operating cash flow 75.99%-1.68M79.57%-1.92M-3.11%-30.14M-3.58%-7.39M-3.73%-6.37M14.47%-7M-20.73%-9.38M52.44%-29.23M52.86%-7.13M35.84%-6.15M
Investing cash flow
Cash flow from continuing investing activities 00797.41%1.35M1,716.13%1.5M107.14%1K-136.84%-135K20.69%-23K94.19%-193K74.09%-93K96.22%-14K
Net PPE purchase and sale --0--0797.41%1.35M1,716.13%1.5M107.14%1K-136.84%-135K20.69%-23K94.19%-193K74.09%-93K96.22%-14K
Cash from discontinued investing activities
Investing cash flow --0--0797.41%1.35M1,716.13%1.5M107.14%1K-136.84%-135K20.69%-23K94.19%-193K74.09%-93K96.22%-14K
Financing cash flow
Cash flow from continuing financing activities 00-384.88%-18.14M00-11.98M-6.16M-75.30%6.37M4,655.91%8.47M-108.45%-2.11M
Net issuance payments of debt --0--0-117.27%-18.11M--0--0---11.86M---6.25M-133.33%-8.33M---6.25M---2.08M
Net common stock issuance --0--0-99.37%92K--0--0--0--92K--14.68M--14.72M---45K
Proceeds from stock option exercised by employees ----------0--0-------------97.97%21K--0----
Net other financing activities -----------125K--0--0--------------------
Cash from discontinued financing activities
Financing cash flow --0--0-384.88%-18.14M--0--0---11.98M---6.16M-75.30%6.37M4,655.91%8.47M-108.45%-2.11M
Net cash flow
Beginning cash position -88.93%4.15M-88.56%6.06M-30.32%53M-76.92%11.94M-69.48%18.32M-45.16%37.43M-30.32%53M-33.91%76.05M-43.59%51.75M-21.81%60.01M
Current changes in cash 91.21%-1.68M87.68%-1.92M-103.55%-46.93M-570.18%-5.88M22.90%-6.37M-131.89%-19.12M-99.54%-15.56M40.90%-23.06M107.98%1.25M-155.18%-8.27M
End cash Position -86.55%2.46M-88.93%4.15M-88.56%6.06M-88.56%6.06M-76.92%11.94M-69.48%18.32M-45.16%37.43M-30.32%53M-30.32%53M-43.59%51.75M
Free cash flow 76.45%-1.68M79.70%-1.92M-3.03%-30.34M-1.92%-7.39M-3.51%-6.38M13.43%-7.14M-21.07%-9.44M54.55%-29.45M53.21%-7.25M38.08%-6.16M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data